Belvedere Trading’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Buy
1,112
+506
+83% +$95.2K ﹤0.01% 543
2026
Q1
$114K Buy
+606
New +$117K ﹤0.01% 504

Other funds holding BBH

Belvedere Trading's BBH Position: Q2 2026 in Review

Belvedere Trading increased its VanEck Biotech ETF (BBH) stake by 83% in Q2 2026, buying an estimated $95.2K and bringing the position to 1,112 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #543.

Belvedere Trading first reported a position in BBH in Q1 2026 and has held it in 2 quarters since. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

  • Belvedere Trading held 1,112 shares of VanEck Biotech ETF worth $226K as of Q2 2026.
  • Belvedere Trading bought 506 VanEck Biotech ETF shares in Q2 2026, an estimated $95.2K.
  • VanEck Biotech ETF made up ﹤0.01% of Belvedere Trading's portfolio in Q2 2026, its #543 holding.
  • Belvedere Trading first reported a position in VanEck Biotech ETF in Q1 2026 and has held it in 2 quarters since.
  • 110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Belvedere Trading's 13F filing for Q2 2026, filed 31 Jul 2026.